Related Experiment Video
Updated: Feb 7, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update
Vincent Cattoir1, Patrice Nordmann
1INSERM U914, Emerging Resistance to Antibiotics, Service de Bactériologie-Virologie, hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine et Université Paris-Sud, K.-Bicêtre, France.
Abstract:
Resistance to quinolones and fluoroquinolones has been increasingly reported among human and veterinary isolates during the last three decades related to their wide clinical use. Until recently, the mechanisms of resistance to quinolones in Enterobacteriaceae were believed to be only chromosome-encoded, i.e. related to modifications of the molecular targets (DNA gyrase and topoisomerase IV), decreased outer-membrane permeability (porin defect) and overexpression of naturally-occurring efflux. However, emergence of plasmid-mediated quinolone resistance (PMQR) has been reported since 1998. Three mechanisms are known to date: Qnr proteins, aminoglycoside acetyltransferase AAC(6')-Ib-cr, and efflux pump QepA. The Qnr proteins protect DNA gyrase and type IV topoisomerase from quinolone inhibition. Four types of Qnr protiens have been reported: QnrA (six variants), QnrB (19 variants), QnrC (one variant), and QnrS (three variants). The AAC(6')-Ib-cr determinant acetylates several fluoroquinolones, such as norfloxacin and ciprofloxacin. The protein AAC(6')-Ib-cr contains two amino acid substitutions as compared to the wild-type enzyme AAC(6')-Ib. Both Qnr and AAC(6')-Ib proteins have been reported worldwide. Lately reported, the plasmid-encoded QepA efflux pump may extrude hydrophilic fluoroquinolones (eg. norfloxacin, ciprofloxacin, and enrofloxacin).
Insights
Emergence of plasmid-mediated quinolone resistance (PMQR) is a growing concern. Mechanisms include Qnr proteins, AAC(6')-Ib-cr, and QepA efflux pumps, contributing to fluoroquinolone resistance in Enterobacteriaceae.
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Quinolone and fluoroquinolone resistance has increased in human and veterinary medicine over 30 years.
- Previously, resistance was attributed to chromosomal modifications, porin defects, and efflux pumps.
- Plasmid-mediated quinolone resistance (PMQR) has emerged since 1998.
Purpose of the Study:
- To review the mechanisms of plasmid-mediated quinolone resistance (PMQR).
- To highlight the roles of Qnr proteins, AAC(6 extprime)-Ib-cr, and QepA in conferring resistance.
- To discuss the global spread of these resistance determinants.
Main Methods:
- Literature review of studies on quinolone resistance mechanisms.
- Analysis of reported genetic determinants of PMQR.
- Compilation of data on the prevalence and variants of Qnr proteins, AAC(6 extprime)-Ib-cr, and QepA.
Main Results:
- Three main PMQR mechanisms identified: Qnr proteins, AAC(6 extprime)-Ib-cr, and QepA.
- Qnr proteins (QnrA, QnrB, QnrC, QnrS) protect DNA gyrase and topoisomerase IV.
- AAC(6 extprime)-Ib-cr acetylates fluoroquinolones; QepA extrudes hydrophilic fluoroquinolones.
Conclusions:
- PMQR mechanisms significantly contribute to fluoroquinolone resistance in Enterobacteriaceae.
- The global dissemination of Qnr, AAC(6 extprime)-Ib-cr, and QepA poses a significant public health challenge.
- Understanding these mechanisms is crucial for developing strategies to combat antimicrobial resistance.
Related Concept Videos
Plasmids
Gram-negative Bacterial Protein Secretion Systems
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
What is a Species?
Keystone Species
Formation of Species

